Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure

改善急性呼吸衰竭的长期结果临床研究

基本信息

  • 批准号:
    8700491
  • 负责人:
  • 金额:
    $ 125.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-15 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): With the aging population, there is a growing number of intensive care unit (ICU) patients with acute lung injury/acute respiratory distress syndrome (ALI) and other causes of acute respiratory failure (ARF). Advances in critical care have decreased ICU patients' mortality, but survivors frequently have substantial post-ICU physical, cognitive and mental health morbidities, which can last for years after discharge. A recent NHLBI workshop recommended that long-term outcomes be a fundamental part of all Phase III trials and indicated a need for determining appropriate measures for ALI/ARF survivors. At present, there is great uncertainty regarding which measurement instruments and analytical methods to use and how to effectively retain a cohort of ALI/ARF survivors for long-term follow-up. The overall goal of this grant is to create and nationally disseminate resources to assist ALI/ARF researchers with designing trials that appropriately evaluate long-term patient outcomes through creating and nationally disseminating: (a) a web-based electronic database of recommended survey instruments and clinical testing methods for evaluating survivors' long-term physical, cognitive and mental health outcomes (Aim 1), (b) resources for maximizing retention of survivors in long-term, longitudinal research studies (Aim 2), and (c) appropriate statistical analysis methods and programs to address "censoring due to death" which occurs when evaluating longitudinal functional outcomes in the setting of high patient mortality (Aim 3). This grant will utilize several methos for creating these resources, including: (a) rigorous systematic reviews, (b) empirical analyses using unique existing datasets, and, (c) structured expert consensus processes. For national dissemination of the resources, the grant will exploit the investigators' expertise in disseminatio methodology and their access and leadership within several existing national networks of relevant users of these clinical research resources.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dale Murray Needham其他文献

Dale Murray Needham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dale Murray Needham', 18)}}的其他基金

Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
适用于危重患者的新型手臂约束装置,可减少不动、镇静、躁动和认知障碍
  • 批准号:
    9984877
  • 财政年份:
    2018
  • 资助金额:
    $ 125.11万
  • 项目类别:
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
适用于危重患者的新型手臂约束装置,可减少不动、镇静、躁动和认知障碍
  • 批准号:
    10017805
  • 财政年份:
    2018
  • 资助金额:
    $ 125.11万
  • 项目类别:
Improving Long-Term Outcomes Clinical Research for Acute Respiratory Failure
改善急性呼吸衰竭的长期结果临床研究
  • 批准号:
    8412810
  • 财政年份:
    2013
  • 资助金额:
    $ 125.11万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 125.11万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了